Evidence map›Paper›PMID 42278975›Full record

ReviewJournal of clinical medicine2026

Clinical Utility and Limitations of Traditional Risk Scores (EuroSCORE, EuroSCORE II, and STS-PROM) in Patients Undergoing TAVI: A Narrative Review.

Filip Klausa, Natalia Świątoniowska-Lonc, Anna Skotny, Marek A Mak, Agnieszka Wysokińska-Kordybach, Jacek Skiba, Krzysztof Ściborski, Waldemar Banasiak, Adrian Doroszko

Abstract readReview
In one paragraph

Review in Journal of clinical medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Filip KlausaDepartment of Cardiac Surgery, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
Natalia Świątoniowska-LoncDepartment of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
Anna SkotnyClinical Research Support Center, 4th Military Hospital, 50-981 Wroclaw, Poland.
Marek A MakDepartment of Cardiac Surgery, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
Agnieszka Wysokińska-KordybachDepartment of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
Jacek SkibaDepartment of Cardiac Surgery, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
Krzysztof ŚciborskiDepartment of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.
Waldemar BanasiakDepartment of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.ORCID 0000-0003-0702-7508
Adrian DoroszkoDepartment of Cardiology, Centre for Heart Diseases, 4th Military Hospital, 50-981 Wroclaw, Poland.ORCID 0000-0001-5472-028X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The rapid evolution of structural heart interventions, particularly transcatheter aortic valve implantation (TAVI), transcatheter edge-to-edge repair (TEER), and hybrid procedures, has significantly expanded treatment options for elderly, frail, and multimorbid patients previously considered high risk or inoperable. However, perioperative risk stratification in this population remains challenging. Traditional risk scores such as EuroSCORE, EuroSCORE II, STS-PROM, CHA

Indexed as

frailtyheart valve prosthesis implantationrisk assessmenttranscatheter aortic valve replacement

Identifiers

PMID42278975
PMCPMC13257576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.